Kevin Holleran

CEO Kevin Holleran sold 52,389 shares of HAYW at $13.79 (now $13.98) under 10b5-1 plan; retains 701,234 shares plus 2,200,236 option shares

Kevin Holleran, President and CEO, executed a scheduled sale of 52,389 shares on 2026-06-01 under a pre-arranged 10b5-1 trading plan adopted on 2025-08-18, reducing his non-derivative holdings from 753,623 to 701,234 shares. The stock was trading $13.98 at current prices versus the $13.79 transaction price, and is -21.2% from its 52-week high of $17.73, reflecting material weakness year-to-date. His prior five sales at HAYW show a mixed record: three produced negative 30-day returns (-14.2%, -3.9%, -3.4%), one produced +12.1%, and one produced +1.4%, indicating inconsistent execution relative to price reversals. Because this trade is scheduled under a 10b5-1 plan rather than discretionary, it does not reflect a timing decision by the insider. Critically, Holleran retains substantial derivative holdings of 2,200,236 stock options, meaning his full economic position in the company remains significant and unchanged by this share reduction.

CEO Kevin Holleran exercised options for 52K shares then sold them the same day at 10x the exercise price; 29th open-market sale in 3 years.

Kevin Holleran, Hayward Holdings' President and CEO, exercised options on 52,389 shares at $1.40 and immediately sold the entire block at $14.5744 on the same day—a characteristic same-day exercise-and-sell pattern typical of option vesting mechanics rather than a statement about conviction. This is the 29th open-market sale Holleran has executed in the past three years, with zero open-market purchases during that same period; he has been exclusively a seller at the open market. The stock is currently trading below its 52-week high and has declined over the past quarter, but without measurable outcome data from his five most recent sales at this ticker—all too recent to evaluate—the timing pattern of his prior exits at Hayward cannot yet be assessed. The company itself remains profitable with steady revenue growth and trades at a reasonable valuation multiple, suggesting fundamental stability despite the stock's recent price weakness.

HAYW CEO Kevin Holleran sold 52,389 shares at $13.42 on 2026-04-01, reducing stake by 7.0% to 701,234 shares.

CEO Kevin Holleran executed a discretionary sale of 52,389 shares at $13.42, representing a 7.0% reduction in his post-transaction holdings to 701,234 shares. The stock has declined 22.3% from its 52-week high and 14.1% over the past 30 days, with Holleran's prior trades at HAYW showing mixed timing: his two most recent 90-day outcomes were both negative (−4.8% and −3.6%), suggesting alignment with downturns. However, his cross-ticker track record shows an average 90-day return of +4.5% following sales across 20 open-market transactions, indicating prior sells have generally preceded gains elsewhere. The company's fundamentals remain solid with $244.3M quarterly revenue and +6.7% annual growth, but the recent price deterioration and CEO equity reduction warrant observation of whether this signals confidence in a near-term recovery or reflects concern about near-term conditions.

HAYW CEO Kevin Holleran sold 52,389 shares ($824,021.34) on 2026-03-02; stock down 10.0% from 52-week high.

Kevin Holleran, President and CEO of Hayward Holdings, sold 52,389 shares at $15.73 on 2026-03-02, reducing his holdings from 772,542 to 720,153 shares. The sale occurs with HAYW trading 10.0% below its 52-week high of $17.22 and down 3.7% over the prior 30 days, indicating a period of stock softness. Holleran's cross-ticker track record shows 35.29% well-timed selling rate across 20 prior sales with an average 90-day return of +4.9%, suggesting his sell timing has been inconsistent. At the same ticker, his 5 prior trades at HAYW show 1 of 2 measurable 90-day outcomes was well-timed (the 2025-11-03 sale preceded a -3.6% 90-day decline), while the 2025-10-01 sale resulted in a +3.9% 90-day gain—a mixed pattern specific to this security. The company maintains solid fundamentals with $244.3M quarterly revenue, $24.0M net income, and 6.7% annual growth, though the elevated P/E of 19.62 relative to sector averages merits monitoring.

HAYW: CEO Holleran sold 52,389 shares ($840.7K) at $16.05 on 2026-02-02, reducing stake -7.8% to 623.5K shares

Kevin Holleran, President and CEO of Hayward Holdings, executed a substantial open-market sale of 52,389 shares at $16.05, reducing his holdings from 675,929 to 623,540 shares and generating $840,743.91 in proceeds. The sale occurred near the 52-week high of $17.22, with the current price of $16.21 trading 5.9% below that high. Examining Holleran's prior trades at Hayward across five recent transactions, his sell timing has been inconsistent: his most recent sale on 2026-01-05 shows +1.4% in the 30-day window, but earlier sells in November and December 2025 resulted in negative 30-day and 90-day returns, and only 1 of 3 prior sells with measurable 90-day outcomes were well-timed (33% well-timed rate at this ticker). This sale represents standard portfolio diversification for a principal shareholder, warranting routine investor monitoring alongside his continued significant beneficial ownership.

HAYW President/CEO Kevin Holleran sold 52,390 shares at $15.99 on 2026-01-05; holds 623,540 post-sale.

Kevin Holleran sold 52,390 shares (-7.8% vs pre-transaction holdings) for $837,899.47 at $15.99, near his recent five-trade pattern on this ticker where he has consistently sold over the past five months. At this ticker specifically, his 5 prior trades show 0 of 3 measurable 90-day outcomes were well-timed (stock rose after 2 of the 3 measurable sales, meaning he sold before gains). His cross-ticker track record across 20 prior sells shows an average 90-day return of +4.9% (poorly timed: stock rose after his sales), with a 33.33% well-timed rate. The current price of $15.58 is -9.5% from the 52-week high of $17.22 and -1.7% lower than 30 days ago, while the stock is +2.1% over 90 days; this recent sale occurred at $15.99, slightly above current levels. The company's fundamentals remain solid with revenue of $244,336,000.00, net income of $24,028,000.00, and +6.0% annual revenue growth, though the P/E of 24.34 reflects a moderately valued position.

CEO Kevin Holleran sold 60,571 shares of HAYW at $16.13 for $976,889.09, reducing holdings by 8.9%.

Kevin Holleran, President and CEO, sold 60,571 shares (60.6K shares) on 2025-12-05 at $16.13 per share, reducing his holdings from 684,111 to 623,540 shares. The sale occurred near the 52-week high of $17.22 (-9.1% from peak), and the company's fundamentals remain solid with $244,336,000.00 in quarterly revenue, $24,028,000.00 in net income, and 6.0% annual revenue growth. However, his prior trades at HAYW show mixed timing outcomes: only 3 of 5 prior measurable sells have 90-day results available, and 0 of those 3 were well-timed (all showed positive 90-day returns, meaning the stock rose after he sold). His broader cross-ticker track record shows a 38.89% well-timed rate on 20 prior sells, which is moderately above a random baseline, but this current ticker exhibits weaker timing discipline. The sale size represents a meaningful reduction in an already-substantial stake, warranting investor attention to whether this reflects portfolio management or a shift in confidence relative to company trajectory.

Holleran (CEO) sold 60,571 shares of HAYW for $1.0M at $16.74 on 2025-11-03; price now $16.19.

Kevin Holleran, President and CEO, sold 60,571 shares (60.6K shares) on 2025-11-03 for $1,013,716.26 ($1.0M), reducing holdings from 684,111 to 623,540 shares (-8.9%). The sale occurred at $16.74, only -6.0% from the 52-week high of $17.22. At his prior HAYW sales, Holleran's 90-day timing record is mixed: of 3 prior measurable 90-day outcomes, 0 were well-timed (stock rose in all three cases), though his most recent HAYW sale on 2025-10-01 showed +11.9% 30-day upside and his June 2025 sale eventually yielded +13.7% at the 90-day mark. His cross-ticker track record shows a 44.44% well-timed rate on 20 prior sells—below 50%—with average 90-day returns of +3.0%, suggesting his sales have not systematically preceded declines. The company fundamentals are solid: revenue of $244.3M, net income of $24.0M, +6.0% annual growth, and a P/E of 25.30. This sale does not align with a clear pattern of prescient exit timing, and the stock has recovered modestly since the transaction date (+4.9% in 30 days).

CEO Kevin Holleran sold 60,571 shares (8.9% of holdings) at $15.16; stock now trades at $15.43, with mixed same-ticker timing history.

Kevin Holleran, as President and CEO, sold 60,571 shares on 2025-10-01 at $15.16, reducing his holdings from 684,111 shares to 623,540 shares. The transaction occurred near current price levels ($15.43 today, -7.0% from 52-week high of $16.60), reflecting modest downward drift over the past month (-2.2% 30-day change) despite broader 90-day strength (+8.7%). His prior trades at HAYW show mixed timing outcomes: three measurable 90-day outcomes yielded returns of +7.4%, +13.7%, and +7.9%, none of which qualify as well-timed (his sells preceded stock rises rather than declines). Cross-ticker, his track record of 20 prior sells achieved a 50.0% well-timed rate at the 90-day horizon with modest average returns (+2.2%), providing limited predictive edge. The sale maintains a substantial post-transaction position (623.5K shares) consistent with ongoing active interest in the company.

CEO Kevin Holleran sold 60.6K shares of HAYW at $15.72 on 2025-09-03 (total $952.1K); holds 623.5K shares post-sale.

Kevin Holleran, President and CEO, executed an open-market sale of 60,571 shares at $15.72 on 2025-09-03, reducing his holdings by 8.9% and generating $952,073.15 in proceeds. His cross-ticker track record shows 20 prior sells with a 90-day well-timed rate of 58.82%, indicating modest predictive accuracy; however, his same-ticker history at HAYW is less decisive—of 2 prior HAYW sales measurable at the 90-day horizon, 0 were well-timed (both resulted in positive returns), suggesting his timing patterns have not held at this specific ticker. The current stock price of $16.01 sits 3.6% below the 52-week high of $16.60 but up 2.8% over 30 days and 14.1% over 90 days, reflecting near-peak valuation; the company's fundamentals show stable growth (+6.0% annual revenue growth) with a P/E of 26.68, indicating a premium multiple. This sale does not appear reactive to deteriorating conditions, but rather represents a reduction in a substantial executive position while the stock trades near cyclical highs.